Impact of erythropoietin and myoinositol versus metformin on insulin resistance in a rat model of polycystic ovary syndrome

References

• Akintayo, C.O., et al., 2021. High fructose-enriched diet synergistically exacerbates endocrine but not metabolic changes in letrozole-induced polycystic ovarian syndrome in Wistar rats. Heliyon, 7 (1), e05890.
   PubMed Web of Science ®Google Scholar
• Atef, M.M., et al., 2019. Therapeutic potential of sodium selenite in letrozole induced polycystic ovary syndrome rat model: Targeting mitochondrial approach (selenium in PCOS). Archives of biochemistry and biophysics, 671, 245–254.
   PubMed Web of Science ®Google Scholar
• Ayaz, A., Alwan, Y., and Farooq, M.U., 2013. Efficacy of combined metformin-clomiphene citrate in comparison with clomiphene citrate alone in infertile women with polycystic ovarian syndrome (PCOS). Journal of medicine and life, 6 (2), 199–201.
   PubMedGoogle Scholar
• Bevilacqua, A., et al., 2019. Myo-inositol and D-chiro-inositol (40:1) reverse histological and functional features of polycystic ovary syndrome in a mouse model. Journal of cellular physiology, 234 (6), 9387–9398.
   PubMed Web of Science ®Google Scholar
• Bhat, K., et al., 2019. Serum erythropoietin levels, breast cancer and breast cancer-initiating cells. Breast cancer research, 21 (1), 1–13.
   PubMedGoogle Scholar
• Cabrera-Cruz, H., et al., 2020. The insulin-sensitizing mechanism of myo-inositol is associated with AMPK activation and GLUT-4 expression in human endometrial cells exposed to a PCOS environment. American journal of physiology-endocrinology and metabolism, 318 (2), E237–e48.
   PubMed Web of Science ®Google Scholar
• Celentano, C., et al., 2016. Myo-inositol supplementation to prevent gestational diabetes mellitus. Current diabetes reports, 16 (3), 30.
   PubMed Web of Science ®Google Scholar
• Chau, J., et al., 2005. Sodium/myo-inositol cotransporter-1 is essential for the development and function of the peripheral nerves. FASEB journal : official publication of the federation of American societies for experimental biology, 19 (13), 1887–1889.
   PubMed Web of Science ®Google Scholar
• Ciotta, L., et al., 2011. Effects of myo-inositol supplementation on oocyte’s quality in PCOS patients: a double blind trial. European review for medical and pharmacological sciences, 15 (5), 509–514.
   PubMed Web of Science ®Google Scholar
• Conde, P., et al., 2019. Effect of the hematopoietic growth factors erythropoietin and kit ligand on bovine oocyte in vitro maturation and developmental competence. Theriogenology, 123, 37–44.
   PubMed Web of Science ®Google Scholar
• Cora, M.C., Kooistra, L., and Travlos, G., 2015. Vaginal cytology of the laboratory rat and mouse: review and criteria for the staging of the estrous cycle using stained vaginal smears. Toxicologic pathology, 43 (6), 776–793.
   PubMed Web of Science ®Google Scholar
• Di Pietro, M., et al., 2015. Metformin regulates ovarian angiogenesis and follicular development in a female polycystic ovary syndrome rat model. Endocrinology, 156 (4), 1453–1463.
   PubMed Web of Science ®Google Scholar
• Gateva, A., Unfer, V., and Kamenov, Z., 2018. The use of inositol(s) isomers in the management of polycystic ovary syndrome: a comprehensive review. Gynecological endocrinology: the official journal of the international society of gynecological endocrinology, 34 (7), 545–550.
   PubMed Web of Science ®Google Scholar
• Glueck, C.J., and Goldenberg, N., 2019. Characteristics of obesity in polycystic ovary syndrome: etiology, treatment, and genetics. Metabolism: clinical and experimental, 92, 108–120.
   PubMed Web of Science ®Google Scholar
• Grzesiak, M., et al., 2021. Altered vitamin D3 metabolism in the ovary and periovarian adipose tissue of rats with letrozole-induced PCOS. Histochemistry and cell biology, 155 (1), 101–116.
   PubMed Web of Science ®Google Scholar
• Günal, M.Y., et al., 2019. Role of erythropoietin and its receptor in the development of endometriosis in rats. Journal of the Turkish German gynecological association, 20 (1), 41–46.
   PubMed Web of Science ®Google Scholar
• Hachey, L.M., et al., 2020. Clinical implications of polycystic ovary syndrome in adolescents. Nursing for women’s health, 24 (2), 115–126.
   PubMedGoogle Scholar
• Heshmati, J., et al., 2021. Effects of curcumin supplementation on blood glucose, insulin resistance and androgens in patients with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial. Phytomedicine: international journal of phytotherapy and phytopharmacology, 80, 153395.
   PubMed Web of Science ®Google Scholar
• Ibrahim, M., et al., 2018. The relation of serum irisin level with metabolic and hormonal changes in rat model of polycystic ovary. Zagazig university medical journal, 24 (5), 409–419.
   Google Scholar
• Im, J.H., et al., 2020. PEGylated erythropoietin protects against brain injury in the MCAO-induced stroke model by blocking NF-κb activation. Biomolecules & therapeutics, 28 (2), 152–162.
   PubMed Web of Science ®Google Scholar
• Jeanes, Y.M., and Reeves, S., 2017. Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges. Nutrition research reviews, 30 (1), 97–105.
   PubMed Web of Science ®Google Scholar
• Jelkmann, W., 2013. Physiology and pharmacology of erythropoietin. Transfusion medicine and hemotherapy: offizielles. Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie, 40 (5), 302–309.
   PubMed Web of Science ®Google Scholar
• Jelkmann, W., 2016. Erythropoietin. Frontiers of hormone research, 47, 115–127.
   PubMed Web of Science ®Google Scholar
• Katz, O., et al., 2010. Erythropoietin treatment leads to reduced blood glucose levels and body mass: insights from murine models. The journal of endocrinology, 205 (1), 87–95.
   PubMed Web of Science ®Google Scholar
• Kauffman, A.S., et al., 2015. A novel letrozole model recapitulates both the reproductive and metabolic phenotypes of polycystic ovary syndrome in female mice. Biology of reproduction, 93 (3):69.
   PubMed Web of Science ®Google Scholar
• Kodo, K., et al., 2017. Erythropoietin (EPO) ameliorates obesity and glucose homeostasis by promoting thermogenesis and endocrine function of classical brown adipose tissue (BAT) in diet-induced obese mice. PloS one, 12 (3), e0173661.
   PubMed Web of Science ®Google Scholar
• Kuo, S.-C., et al., 2018. Investigation of the pronounced erythropoietin-induced reduction in hyperglycemia in type 1-like diabetic rats. Endocrine journal, 65 (2), 181–191.
   PubMed Web of Science ®Google Scholar
• Kupreeva, M., et al., 2019. Effect of metformin and flutamide on insulin, lipogenic and androgen-estrogen signaling, and cardiometabolic risk in a PCOS-prone metabolic syndrome rodent model. American journal of physiology. Endocrinology and metabolism, 316 (1), E16–e33.
   PubMed Web of Science ®Google Scholar
• Laganà, A.S., et al., 2018. Inositol in polycystic ovary syndrome: restoring fertility through a pathophysiology-based approach. Trends in endocrinology and metabolism, 29 (11), 768–780.
   PubMed Web of Science ®Google Scholar
• Liu, X., et al., 2020. Role of the erythropoietin receptor in lung cancer cells: erythropoietin exhibits angiogenic potential. Journal of cancer, 11 (20), 6090–6100.
   PubMed Web of Science ®Google Scholar
• Lobo, R.A. Jr., et al., 1983. Psychological stress and increases in urinary norepinephrine metabolites, platelet serotonin, and adrenal androgens in women with polycystic ovary syndrome. American journal of obstetrics and gynecology, 145 (4), 496–503.
   PubMed Web of Science ®Google Scholar
• Lu, J., et al., 2012. Erythropoietin attenuates cardiac dysfunction by increasing myocardial angiogenesis and inhibiting interstitial fibrosis in diabetic rats. Cardiovascular diabetology, 11 (1), 105–111.
   PubMed Web of Science ®Google Scholar
• Maliqueo, M., Benrick, A., and Stener-Victorin, E., 2014. Rodent models of polycystic ovary syndrome: phenotypic presentation, pathophysiology, and the effects of different interventions. Seminars in reproductive medicine, 32 (03), 183–193..
   PubMedGoogle Scholar
• Maliqueo, M., et al., 2013. Continuous administration of a P450 aromatase inhibitor induces polycystic ovary syndrome with a metabolic and endocrine phenotype in female rats at adult age. Endocrinology, 154 (1), 434–445.
   PubMed Web of Science ®Google Scholar
• Maqbool, M., et al., 2019. Insulin resistance and polycystic ovary syndrome: A. Journal of drug delivery and therapeutics, 9 (1-s), 433–436.
   Google Scholar
• Meng, R., et al., 2013. Erythropoietin inhibits gluconeogenesis and inflammation in the liver and improves glucose intolerance in high-fat diet-fed mice. PloS one, 8 (1), e53557.
   PubMed Web of Science ®Google Scholar
• Merviel, P., et al., 2021. Impact of myo-inositol treatment in women with polycystic ovary syndrome in assisted reproductive technologies. Reproductive health, 18 (1), 13.
   PubMed Web of Science ®Google Scholar
• Miller, R.A., et al., 2013. Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP. Nature, 494 (7436), 256–260.
   PubMed Web of Science ®Google Scholar
• Nas, K., and Tűű, L., 2017. A comparative study between myo-inositol and metformin in the treatment of insulin-resistant women. European review for medical and pharmacological sciences, 21 (2 Suppl), 77–82.
   PubMedGoogle Scholar
• Noxon, V., et al., 2017. Tale of two erythropoiesis-stimulating agents: utilization, dosing, litigation, and costs of darbepoetin and epoetin among South Carolina Medicaid-covered patients with cancer and chemotherapy-induced anemia. Journal of oncology practice, 13 (6), e562–e73.
   PubMed Web of Science ®Google Scholar
• Patel, R., and Shah, G., 2018. High-fat diet exposure from pre-pubertal age induces polycystic ovary syndrome (PCOS) in rats. Reproduction, 155 (2), 139–149.
   Web of Science ®Google Scholar
• Rababa’h, A.M., Matani, B.R., and Ababneh, M.A., 2020. The ameliorative effects of marjoram in dehydroepiandrosterone induced polycystic ovary syndrome in rats. Life sciences, 261, 118353.
   PubMed Web of Science ®Google Scholar
• Robinson, S., et al., 1993. The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries. Clinical endocrinology, 39 (3), 351–355.
   PubMed Web of Science ®Google Scholar
• Scully, M.S., et al., 2011. A novel EPO receptor agonist improves glucose tolerance via glucose uptake in skeletal muscle in a mouse model of diabetes. Experimental diabetes research, 2011, 910159.
   PubMedGoogle Scholar
• Tosi, F., et al., 2015. Total body fat and central fat mass independently predict insulin resistance but not hyperandrogenemia in women with polycystic ovary syndrome. The journal of clinical endocrinology & metabolism, 100 (2), 661–669.
   PubMed Web of Science ®Google Scholar
• Tuzcu, A., et al., 2004. The comparison of insulin sensitivity in non-diabetic hemodialysis patients treated with and without recombinant human erythropoietin. Hormone and metabolic research, 36 (10), 716–720.
   PubMed Web of Science ®Google Scholar
• Witchel, S.F., Oberfield, S.E., and Peña, A.S., 2019. Polycystic ovary syndrome: pathophysiology, presentation, and treatment with emphasis on adolescent girls. Journal of the endocrine society, 3 (8), 1545–1573.
   PubMed Web of Science ®Google Scholar
• Yasuda, Y., et al., 1998. Estrogen-dependent production of erythropoietin in uterus and its implication in uterine angiogenesis. The journal of biological chemistry, 273 (39), 25381–25387.
   PubMed Web of Science ®Google Scholar
• Yasuda, Y., et al., 2001. Expression of erythropoietin in human female reproductive organs. Italian journal of anatomy and embryology = Archivio italiano di anatomia ed embriologia, 106 (2 Suppl 2), 215–222.
   PubMedGoogle Scholar
• Zhang, Y., et al., 2020. Decreased insulin resistance by myo-inositol is associated with suppressed interleukin 6/phospho-STAT3 signaling in a rat polycystic ovary syndrome model. Journal of medicinal food, 23 (4), 375–387.
   PubMed Web of Science ®Google Scholar